DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Eriksson BI, Dahl OE, Rosencher N , et al. RE-MODEL Study Group.
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
J Thromb Haemost 2007;
5 (11) 2178-2185
We do not assume any responsibility for the contents of the web pages of other providers.